Ragnhild Helseth

Dr. Ragnhild Helseth


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KKKristine Mørk Kindberg
Kristine Mørk Kindberg
JNJostein Nordeng
Jostein Nordeng
MLMiriam Sjåstad Langseth
Miriam Sjåstad Langseth
HSHossein Schandiz
Hossein Schandiz
BRBorghild Roald
Borghild Roald
RHRagnhild Helseth
Ragnhild Helseth
Inflammation contributes to myocardial injury in ST-elevation myocardial infarction (STEMI). Interleukin-6 receptor (IL-6R) inhibition has been shown to mitigate myocardial injury and reduce levels of the prothrombotic and inflammatory mediator, neutrophil extracellular traps (NETs). The enzyme peptidylarginine deiminase 4 (PAD4) is central in NET formation. We hypothesized that PAD4 links IL-6R activation and NET formation. Methods: We conducted thrombus aspiration and peripheral blood sampling in 33 STEMI patients. In thrombi and leukocytes, we quantified the mRNA of IL-6, IL-6R, and PAD4. In peripheral blood, the protein levels of IL-6, IL-6R, PAD4, dsDNA, H3Cit, MPO-DNA, and troponin T were quantified. Results: In thrombi and circulating leukocytes, PAD4 mRNA was associated with IL-6R mRNA (thrombi: β = 0.34, 95% CI [0.16–0.53], p = 0.001, circulating leukocytes: β = 0.92, 95% CI [0.07–1.77], p = 0.036). There were no correlations between PAD4 and IL-6 in thrombi and leukocytes. The protein levels of IL-6R were associated with the NET marker H3Cit (rs = 0.40, p = 0.02). In thrombi, PAD4 mRNA was associated with high levels of troponin T (β = 1.15 95% CI [0.27–2.04], p = 0.013). Conclusion: We demonstrate an association between PAD4, IL-6R, and troponin release in STEMI patients. Our findings indicate a PAD4-mediated connection between IL-6R and NET formation and highlight PAD4 as a potential treatment target for mitigating inflammation and myocardial injury in STEMI.

5 September 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
VBVibeke Bratseth
Vibeke Bratseth
JNJostein Nordeng
Jostein Nordeng
RHRagnhild Helseth
Ragnhild Helseth
SSSvein Solheim
Svein Solheim
SÅSissel Åkra
Sissel Åkra
ISIngebjørg Seljeflot
Ingebjørg Seljeflot
Microvesicles (MVs) are actively secreted by cells. The NLRP3-inflammasome and the interleukin 6 (IL-6)-pathways are central in cardiovascular disease. Knowledge of how the inflammasome influences the MVs is limited. In a cross-sectional study, we assessed whether MVs in plasma associate with genes encoding inflammasome signalling in coronary thrombi. Moreover, any relationships between inflammasome activation and phosphatidylserine (PS) externalization, determined through Annexin V (AV+) labelling, and myocardial injury, assessed by cardiac troponin T (cTnT), were analysed. Intracoronary thrombi and blood samples from STEMI patients (n = 33) were investigated. mRNA of NLRP3, caspase-1, interleukin-1β (IL-1β), interleukin-18 (IL-18), IL-6, soluble IL-6-receptor (sIL-6R), and glycoprotein-130 (gp130) were isolated from the thrombi and relatively quantified by RT-PCR. MVs were analysed by flow cytometry. Total AV+ MVs, mainly reflecting hypercoagulability, correlated positively to NLRP3 gene expression (r = 0.545, p = 0.009). A similar pattern was seen for platelet, endothelial and leukocyte derived MVs, separately. The majority of the MVs were AV− (96%). Total and AV− MVs correlated inversely with IL-1β (r = −0.399 and −0.438, respectively, p < 0.05, both) and gp130 (r = −0.457 and −0.502, respectively, p < 0.05, both). No correlations between MVs and cTnT were observed. Our findings indicate an association between NLRP3-inflammasome in coronary thrombi and procoagulant AV+ MVs in STEMI patients. The inverse relationships between AV− MVs and the gene expression of inflammasome activation may indicate an immuno-dampening role of this subpopulation.

13 October 2026 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
SSSindre T. Strandberg
Sindre T. Strandberg
TOTrine B. Opstad
Trine B. Opstad
ARAndreas Romaine
Andreas Romaine
EEEmil Espe
Emil Espe
MSMani Sadredini
Mani Sadredini
RHRagnhild Helseth
Ragnhild Helseth
Introduction: Ageing is an independent risk factor for cardiovascular disease (CVD). Preclinical models of ageing are needed to better understand human diseases. Telomere shortening is a critical process in cellular ageing and senescence. In humans, it is well-established that telomere shortening in circulating leukocytes is associated with CVD, however, whether this applies to common preclinical models remains disputable. We investigated leukocyte telomere length (LTL), cardiac telomere length (CTL), and age-related cardiac remodeling and functional decline in commonly used laboratory rats. Methods: Sprague-Dawley rats ( n = 51) were euthanized at 3, 9, 16, or 24 months (mo), respectively. Cardiac function was assessed by echocardiography. Relative telomere length, mRNA levels of telomerase and signature genes involved in inflammation and fibrosis were quantified in circulating leukocytes and left ventricular tissue by quantitative or digital droplet PCR (qPCR or ddPCR, respectively). Results: Rats with increasing chronological age (16/24 months compared to 9 months) exhibited cardiac hypertrophy and diastolic dysfunction, as evidenced by increased septal and posterior wall thickness, and elevated E/e’ ratio, and increased cardiac expression of central inflammatory ( Il6 ) and fibrotic ( Ctgf ) genes. Relative LTL and CTL remained unchanged across chronological age groups (LTL: 9 months 1.000 vs. 16 months 0.939 vs. 24 months 1.120, p = 0.37; and CTL: 9 months 1.000 vs. 16 months 1.021 vs. 24 months 0.897, p = 0.42). CTL and LTL did not correlate ( r = −0.027, p = 0.89). No association with cardiac dysfunction was observed, neither for LTL nor CTL. Discussion: Laboratory rats of high age exhibited cardiac hypertrophy and dysfunction, resembling human cardiac ageing, however we found no evidence of shorter telomere lengths in circulating leukocytes nor cardiac cells, suggesting a translational gap.